MiSight® 1 day soft contact lenses are specifically designed for myopia control and are FDA approved* to slow the progression of myopia in children aged 8-12 at the initiation of treatment.1†
Find a MiSight® 1 day certified eye doctor near you.
Indications and Important Safety Information:
RX Only
Results May Vary.
ATTENTION: Reference the Patient Information Booklet for a complete listing of Indications and Important Safety Information. *Indication: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters(spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal. Warnings: Problems with contact lenses could result in serious injury to the eye. Do not expose contact lenses to water while wearing them. Under certain circumstances MiSight® lenses optical design can cause reduced image contrast/ghosting/halo/glare in some patients that may cause difficulties with certain visually-demanding tasks. Precautions: Daily wear single use only. Patient should always dispose when lenses are removed. No overnight wear. Patients should exercise extra care if performing potentially hazardous activities. Adverse events: Including but not limited to infection/inflammation/ulceration/abrasion of the cornea, other parts of the eye or eyelids. Some of these adverse reactions can cause permanent or temporary loss of vision. If you notice any of the stated in your child, immediately have your child remove the lenses and contact your eye care professional.
†Compared to a single vision 1 day lens over a 3 year period.
References:
- 1. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556-567. Optom Vis Sci 2020;97(E-abstract): 200038.